Nanomaterial Interventions in Pathological Biomolecular Phase Transitions of Neurodegeneration and Cancer
Small · 2026
DOI: 10.1002/smll.75569 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, 2026. Verfasst von Ruonan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, People's Republ…. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms, Phase Transition, Neurodegenerative Diseases. Die Arbeit nennt 238 Literaturangaben. Gefördert von: NSFC, National Natural Science Foundation of China.
Abstract (Originalsprache)
Liquid–liquid phase separation (LLPS) is a physical process that drives the formation of biomolecular condensates, which coordinate cellular biochemical reactions in space and time. Nevertheless, these metastable condensates are susceptible to various disturbances, which trigger the occurrence of abnormal phase transitions. In neurodegeneration, this process promotes the development of misfolded proteins into toxic fibrils. In cancer, LLPS affects multiple stages of its occurrence and progression, including oncogenic signaling, gene expression, angiogenesis, metabolic reprogramming, and invasive growth. The disordered regions of proteins play an important role in these abnormal phase transitions. However, in this area, traditional lock‐and‐key pharmacology faces major challenges. Notably, due to the large specific surface area, multivalence, and tunability, nanotechnology shows substantial potential for intervention at multiple stages of pathological phase separation. These targets encompass monomers, liquid condensates, oligomers, and fibrils. In addition to traditional strategies, emerging frontiers include nanomaterial‐induced synthetic condensates for component sequestration and targeted disruption of oncogenic transcriptional hubs. Furthermore, computational modeling is beginning to transform LLPS research from mechanism discovery toward material rational engineering. This review provides a strategic framework for utilizing nanotechnology as a precision intervention to modulate LLPS, offering a clear path for the intervention of pathological phase separation in diverse diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, People's Republic of China.
- MOE Key Laboratory of High Performance Polymer Materials & Technology and State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry & Chemical Engineering, Nanjing University, Nanjing, People's…
- College of Environment & Safety Engineering, Fuzhou University, Fuzhou, People's Republic of China.
- University of Chinese Academy of Sciences, Beijing, People's Republic of China.
ORCID-Profile: Ruonan Wang, Wei Wu, Xiqun Jiang, Hongli Bao
Förderung
- NSFC
- National Natural Science Foundation of China
Zitieren
APA
Wang, R., Wu, W., Jiang, X., & Bao, H. (2026). Nanomaterial Interventions in Pathological Biomolecular Phase Transitions of Neurodegeneration and Cancer. Small. https://doi.org/10.1002/smll.75569
Vancouver
Wang R, Wu W, Jiang X, Bao H. Nanomaterial Interventions in Pathological Biomolecular Phase Transitions of Neurodegeneration and Cancer. Small. 2026. doi:10.1002/smll.75569
BibTeX
@article{Wang2026,
author = {Wang, Ruonan and Wu, Wei and Jiang, Xiqun and Bao, Hongli},
title = {Nanomaterial Interventions in Pathological Biomolecular Phase Transitions of Neurodegeneration and Cancer},
journal = {Small},
year = {2026},
doi = {10.1002/smll.75569}
}
EUVIMED